Skip to main content
Top
Published in: Neuroscience Bulletin 2/2019

01-04-2019 | Original Article

Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy

Authors: Xiaoling Zhang, Bing Sun, Xing Wang, Hui Lu, Fangjie Shao, Annemieke J. M. Rozemuller, Huazheng Liang, Chong Liu, Jiadong Chen, Manli Huang, Keqing Zhu

Published in: Neuroscience Bulletin | Issue 2/2019

Login to get access

Abstract

Primary age-related tauopathy (PART) is characterized by tau neurofibrillary tangles (NFTs) in the absence of amyloid plaque pathology. In the present study, we analyzed the distribution patterns of phosphorylated 43-kDa TAR DNA-binding protein (pTDP-43) in the brains of patients with PART. Immunohistochemistry and immunofluorescence double-labeling in multiple brain regions was performed on brain tissues from PART, Alzheimer’s disease (AD), and aging control cases. We examined the regional distribution patterns of pTDP-43 intraneuronal inclusions in PART with Braak NFT stages > 0 and ≤ IV, and a Thal phase of 0 (no beta-amyloid present). We found four stages which indicated potentially sequential dissemination of pTDP-43 in PART. Stage I was characterized by the presence of pTDP-43 lesions in the amygdala, stage II by such lesions in the hippocampus, stage III by spread of pTDP-43 to the neocortex, and stage IV by pTDP-43 lesions in the putamen, pallidum, and insular cortex. In general, the distribution pattern of pTDP-43 pathology in PART cases was similar to the early TDP-43 stages reported in AD, but tended to be more restricted to the limbic system. However, there were some differences in the distribution patterns of pTDP-43 between PART and AD, especially in the dentate gyrus of the hippocampus. Positive correlations were found in PART between the Braak NFT stage and the pTDP-43 stage and density.
Appendix
Available only for authorised users
Literature
1.
go back to reference Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 2014, 128: 755–766.CrossRefPubMedPubMedCentral Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, Abner EL, Alafuzoff I, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 2014, 128: 755–766.CrossRefPubMedPubMedCentral
2.
3.
go back to reference Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, et al. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol 2015, 129: 757–762.CrossRefPubMedPubMedCentral Jellinger KA, Alafuzoff I, Attems J, Beach TG, Cairns NJ, Crary JF, et al. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol 2015, 129: 757–762.CrossRefPubMedPubMedCentral
4.
go back to reference Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314: 130–133.CrossRefPubMed Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314: 130–133.CrossRefPubMed
5.
go back to reference Cykowski MD, Powell SZ, Peterson LE, Appel JW, Rivera AL, Takei H, et al. Clinical significance of TDP-43 neuropathology in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2017, 76: 402–413.CrossRefPubMedPubMedCentral Cykowski MD, Powell SZ, Peterson LE, Appel JW, Rivera AL, Takei H, et al. Clinical significance of TDP-43 neuropathology in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2017, 76: 402–413.CrossRefPubMedPubMedCentral
6.
go back to reference Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 2008, 64: 60–70.CrossRefPubMedPubMedCentral Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 2008, 64: 60–70.CrossRefPubMedPubMedCentral
7.
go back to reference Warraich ST, Yang S, Nicholson GA, Blair IP. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases. Int J Biochem Cell Biol 2010, 42: 1606–1609.CrossRefPubMed Warraich ST, Yang S, Nicholson GA, Blair IP. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases. Int J Biochem Cell Biol 2010, 42: 1606–1609.CrossRefPubMed
8.
go back to reference Josephs KA, Murray ME, Whitwell JL, Parisi JE, Petrucelli L, Jack CR, et al. Staging TDP-43 pathology in Alzheimer’s disease. Acta Neuropathol 2014, 127: 441–450.CrossRefPubMed Josephs KA, Murray ME, Whitwell JL, Parisi JE, Petrucelli L, Jack CR, et al. Staging TDP-43 pathology in Alzheimer’s disease. Acta Neuropathol 2014, 127: 441–450.CrossRefPubMed
9.
go back to reference Josephs KA, Murray ME, Whitwell JL, Tosakulwong N, Weigand SD, Petrucelli L, et al. Updated TDP-43 in Alzheimer’s disease staging scheme. Acta Neuropathol 2016, 131: 571–585.CrossRefPubMedPubMedCentral Josephs KA, Murray ME, Whitwell JL, Tosakulwong N, Weigand SD, Petrucelli L, et al. Updated TDP-43 in Alzheimer’s disease staging scheme. Acta Neuropathol 2016, 131: 571–585.CrossRefPubMedPubMedCentral
10.
go back to reference Brettschneider J, Del Tredici K, Irwin DJ, Grossman M, Robinson JL, Toledo JB, et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol 2014, 127: 423–439.CrossRefPubMedPubMedCentral Brettschneider J, Del Tredici K, Irwin DJ, Grossman M, Robinson JL, Toledo JB, et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). Acta Neuropathol 2014, 127: 423–439.CrossRefPubMedPubMedCentral
11.
go back to reference Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 2013, 74: 20–38.CrossRefPubMedPubMedCentral Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, Irwin DJ, Grossman M, et al. Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 2013, 74: 20–38.CrossRefPubMedPubMedCentral
12.
go back to reference Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K, et al. Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies. Acta Neuropathol 2009, 117: 125–136.CrossRefPubMed Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K, et al. Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies. Acta Neuropathol 2009, 117: 125–136.CrossRefPubMed
13.
go back to reference Uchino A, Takao M, Hatsuta H, Sumikura H, Nakano Y, Nogami A, et al. Incidence and extent of TDP-43 accumulation in aging human brain. Acta Neuropathol Commun 2015, 3: 35.CrossRefPubMedPubMedCentral Uchino A, Takao M, Hatsuta H, Sumikura H, Nakano Y, Nogami A, et al. Incidence and extent of TDP-43 accumulation in aging human brain. Acta Neuropathol Commun 2015, 3: 35.CrossRefPubMedPubMedCentral
14.
go back to reference Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 2007, 61: 435–445.CrossRefPubMedPubMedCentral Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer’s disease. Ann Neurol 2007, 61: 435–445.CrossRefPubMedPubMedCentral
15.
go back to reference Hu WT, Josephs KA, Knopman DS, Boeve BF, Dickson DW, Petersen RC, et al. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol 2008, 116: 215–220.CrossRefPubMedPubMedCentral Hu WT, Josephs KA, Knopman DS, Boeve BF, Dickson DW, Petersen RC, et al. Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease. Acta Neuropathol 2008, 116: 215–220.CrossRefPubMedPubMedCentral
16.
go back to reference Nascimento C, Suemoto CK, Rodriguez RD, Alho AT, Leite RP, Farfel JM, et al. Higher prevalence of TDP-43 proteinopathy in cognitively normal Asians: a clinicopathological study on a multiethnic sample. Brain Pathol 2016, 26: 177–185.CrossRefPubMed Nascimento C, Suemoto CK, Rodriguez RD, Alho AT, Leite RP, Farfel JM, et al. Higher prevalence of TDP-43 proteinopathy in cognitively normal Asians: a clinicopathological study on a multiethnic sample. Brain Pathol 2016, 26: 177–185.CrossRefPubMed
17.
go back to reference Wilson AC, Dugger BN, Dickson DW, Wang DS. TDP-43 in aging and Alzheimer’s disease - a review. Int J Clin Exp Pathol 2011, 4: 147–155.PubMedPubMedCentral Wilson AC, Dugger BN, Dickson DW, Wang DS. TDP-43 in aging and Alzheimer’s disease - a review. Int J Clin Exp Pathol 2011, 4: 147–155.PubMedPubMedCentral
18.
go back to reference Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, Kwong LK, et al. Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch Neurol 2010, 67: 1238–1250.CrossRefPubMedPubMedCentral Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, Kwong LK, et al. Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch Neurol 2010, 67: 1238–1250.CrossRefPubMedPubMedCentral
19.
go back to reference Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM, et al. TDP-43 is a key player in the clinical features associated with Alzheimer’s disease. Acta Neuropathol 2014, 127: 811–824.CrossRefPubMedPubMedCentral Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM, et al. TDP-43 is a key player in the clinical features associated with Alzheimer’s disease. Acta Neuropathol 2014, 127: 811–824.CrossRefPubMedPubMedCentral
20.
go back to reference Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S, et al. TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 2011, 122: 703–713.CrossRefPubMed Davidson YS, Raby S, Foulds PG, Robinson A, Thompson JC, Sikkink S, et al. TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 2011, 122: 703–713.CrossRefPubMed
21.
go back to reference Josephs KA, Murray ME, Tosakulwong N, Whitwell JL, Knopman DS, Machulda MM, et al. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). Acta Neuropathol 2017, 133: 705–715.CrossRefPubMedPubMedCentral Josephs KA, Murray ME, Tosakulwong N, Whitwell JL, Knopman DS, Machulda MM, et al. Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). Acta Neuropathol 2017, 133: 705–715.CrossRefPubMedPubMedCentral
22.
go back to reference Smith VD, Bachstetter AD, Ighodaro E, Roberts K, Abner EL, Fardo DW, et al. Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi. Brain Pathol 2018, 28: 264–273.CrossRefPubMed Smith VD, Bachstetter AD, Ighodaro E, Roberts K, Abner EL, Fardo DW, et al. Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi. Brain Pathol 2018, 28: 264–273.CrossRefPubMed
23.
go back to reference Chang XL, Tan MS, Tan L, Yu JT. The role of TDP-43 in Alzheimer’s disease. Mol Neurobiol 2016; 53: 3349–3359.CrossRefPubMed Chang XL, Tan MS, Tan L, Yu JT. The role of TDP-43 in Alzheimer’s disease. Mol Neurobiol 2016; 53: 3349–3359.CrossRefPubMed
24.
go back to reference Arnold SJ, Dugger BN, Beach TG. TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies. Acta Neuropathol 2013, 126: 51–57.CrossRefPubMedPubMedCentral Arnold SJ, Dugger BN, Beach TG. TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies. Acta Neuropathol 2013, 126: 51–57.CrossRefPubMedPubMedCentral
25.
go back to reference McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J. TDP-43 pathology in Alzheimer’s disease, dementia with Lewy bodies and ageing. Brain Pathol 2017, 27: 472–479.CrossRefPubMed McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J. TDP-43 pathology in Alzheimer’s disease, dementia with Lewy bodies and ageing. Brain Pathol 2017, 27: 472–479.CrossRefPubMed
26.
go back to reference Wang QH, Wang X, Bu XL, Lian Y, Xiang Y, Luo HB, et al. Comorbidity burden of dementia: A hospital-based retrospective study from 2003 to 2012 in seven cities in China. Neurosci Bull 2017, 33: 703–710.CrossRefPubMedPubMedCentral Wang QH, Wang X, Bu XL, Lian Y, Xiang Y, Luo HB, et al. Comorbidity burden of dementia: A hospital-based retrospective study from 2003 to 2012 in seven cities in China. Neurosci Bull 2017, 33: 703–710.CrossRefPubMedPubMedCentral
27.
go back to reference Nag S, Yu L, Wilson RS, Chen EY, Bennett DA, Schneider JA. TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD. Neurology 2017, 88: 653–660.CrossRefPubMedPubMedCentral Nag S, Yu L, Wilson RS, Chen EY, Bennett DA, Schneider JA. TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD. Neurology 2017, 88: 653–660.CrossRefPubMedPubMedCentral
Metadata
Title
Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy
Authors
Xiaoling Zhang
Bing Sun
Xing Wang
Hui Lu
Fangjie Shao
Annemieke J. M. Rozemuller
Huazheng Liang
Chong Liu
Jiadong Chen
Manli Huang
Keqing Zhu
Publication date
01-04-2019
Publisher
Springer Singapore
Published in
Neuroscience Bulletin / Issue 2/2019
Print ISSN: 1673-7067
Electronic ISSN: 1995-8218
DOI
https://doi.org/10.1007/s12264-018-0300-0

Other articles of this Issue 2/2019

Neuroscience Bulletin 2/2019 Go to the issue